Healthcare Services

Rare Disease Genetic Testing Market Growth Expected to Reach $2.18 Billion by 2030 with 13.1% CAGR

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Rare Disease Genetic Testing Market From 2026 To 2030?

The market for rare disease genetic testing has seen a swift expansion in its size over recent years. This market is projected to expand from $1.17 billion in 2025 to reach $1.33 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.7%. Historically, this expansion has been driven by several factors, including advancements in genomic sequencing technologies, an increase in rare disease research programs, heightened public awareness of genetic conditions, the establishment of specialized diagnostic laboratories, and the development of clinical genetics programs.

The rare disease genetic testing market size is projected to witness substantial expansion over the coming years. It is anticipated to reach $2.18 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.1%. This growth during the forecast period is attributable to the escalating demand for personalized medicine, rising investments in genomic data analytics, the broadening of population-scale genetic screening, the increasing integration of genetics into routine clinical care, and advancements in bioinformatics platforms. Significant trends for the forecast period include the increasing adoption of next-generation sequencing for rare diseases, the growing utilization of AI-driven variant interpretation, the expansion of comprehensive genetic testing panels, the rising integration of genetic data with clinical decision systems, and an enhanced focus on early and accurate diagnosis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27404&type=smp

What Major Drivers Are Influencing Demand In The Rare Disease Genetic Testing Market?

The expanding prevalence of genetic disorders is anticipated to fuel the future expansion of the rare disease genetic testing market. These disorders are defined as health conditions resulting from irregularities in a person’s deoxyribonucleic acid, which can be passed down from one or both parents or originate from novel mutations. The rise in genetic disorders is linked to an increase in parental age, given that older parents face a greater likelihood of transmitting genetic mutations to their offspring. Genetic testing for rare diseases assists in diagnosing these conditions by pinpointing particular mutations, thus allowing for precise and prompt identification. Such testing aids personalized treatment strategies, thereby improving patient care and boosting long-term health results. For example, data from May 2024, provided by the National Health Service, a UK-based government department, indicates that 17,000 individuals are affected by sickle cell disease, an inherited genetic blood disorder, with approximately 250 new diagnoses annually. Consequently, the growing incidence of genetic disorders is propelling the expansion of the rare disease genetic testing market.

Which Segments Are Included In The Analysis Of The Rare Disease Genetic Testing Market?

The rare disease genetic testing market covered in this report is segmented –

1) By Disease Type: Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine And Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Other Disease Types

2) By Technology: Next-Generation Sequencing, Sanger Sequencing, Polymerase Chain Reaction Based Testing, Array Based Testing, Fluorescence In Situ Hybridization, Other Technologies

3) By Specialty: Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests

4) By End-User: Hospitals And Clinics, Research Laboratories And Contract Research Organizations, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Immunological Disorders: Autoimmune Disorders, Allergic Conditions, Primary Immunodeficiency Disorders, Inflammatory Disorders

2) By Cardiovascular Disorders: Congenital Heart Defects, Cardiomyopathies, Aortic Aneurysms, Pulmonary Hypertension

3) By Neurological Disease: Neurodegenerative Disorders, Neuromuscular Disorders, Epileptic Syndromes, Movement Disorders

4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders, Thyroid Disorders, Adrenal Disorders, Diabetes Related Genetic Conditions

5) By Hematological Diseases: Hemophilia, Thalassemia, Sickle Cell Disease, Clotting Disorders

6) By Dermatological Disease: Genetic Skin Disorders, Connective Tissue Disorders, Pigmentary Disorders, Keratinization Disorders

7) By Other Disease Types: Skeletal Dysplasia, Renal Genetic Disorders, Ophthalmic Genetic Conditions, Gastrointestinal Genetic Conditions

What Key Developments And Trends Are Impacting The Rare Disease Genetic Testing Market?

Major companies engaged in the rare disease genetic testing market are prioritizing the development of technologically advanced solutions, such as digital genomics platforms, to boost the speed, precision, and scalability of diagnosing rare diseases. Digital genomics platforms are sophisticated software systems that integrate genomic data analysis, interpretation, and reporting capabilities to streamline and expedite genetic testing and diagnosis. For instance, in March 2025, Strand Life Sciences Private Limited, an India-based computer software company, unveiled the StrandOmics Portal, a digital platform designed to improve the efficiency and accuracy of rare disease diagnosis. This portal offers clinicians comprehensive insights into genetic variants, enabling quicker and more exact diagnoses. It supports advanced variant interpretation, including for prenatal diagnostics, and allows for independent reviews of genetic data. This launch demonstrates a strong commitment to progressing precision medicine and equipping healthcare professionals with effective tools to enhance patient outcomes.

Which Key Industry Participants Are Active In The Rare Disease Genetic Testing Market?

Major companies operating in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Artemis DNA Inc., BGI Genomics Co. Ltd., GeneDx Inc., Genomics England Ltd.

Read the full rare disease genetic testing market report here:

https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Rare Disease Genetic Testing Market?

North America was the largest region in the rare disease genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Rare Disease Genetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27404&type=smp

Browse Through More Reports Similar to the Global Rare Disease Genetic Testing Market 2026, By The Business Research Company

Rare Diseases Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Clinical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Rare Kidney Diseases Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795